intravitreal, VEGF Therapy, macula


Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Cover Image Not Available

October 2009


Peer Reviewed
By:  Jagdeep Singh Gandhi, BSc (Hons), MBChB, MRCSEd, FRCOphth
Assessment of Risk Factor Profiles in Acute Retinovascular Occlusion

IOL Fixation Techniques
By:  Gábor B. Scharioth, MD
A European surgeon offers his views on the treatment of luxated intraocular lenses

IOL Fixation Techniques
By:  Karim N. Jamal, MD; Pravin U. Dugel, MD
The case for ACIOL

Case Study
By:  Felipe P. P. De Almeida, MD; Kyle J. Alliman, MD; Harry W. Flynn, Jr., MD
Photic Maculopathy Following Exchange of Crystalens: Clinical and Spectral-domain OCT Features

The Problems With EMR
By:  Andrew E. Mathis, PhD, Medical Editor
What's holding practices back from adopting electronic medical systems? Why are predicted efficiencies not materializing?

Use and Abuse of Modifier -25
By:  Kevin J. Corcoran, C.O.E., C.P.C., F.N.A.O.
Are you using modifier -25 correctly in submitting reimbursement forms to CMS for intravitreal injection?

Fine-Tuning Your Anti-VEGF Injection Protocols
By:  Andrew E. Mathis, PhD, Medical Editor
The second article in our series recapping research and analysis presented at our annual meeting

Photo Essay
By:  Muralidharan R. Upendran, MBBS, MRCOphth; Giuliana Silvestri, MD, FRCPEd, FRCSEd, FRCOphth
Treatment of CNV Secondary to Sorsby's Macular Dystrophy With Intravitreal Ranibizumab

AION and Retinal Artery Occlusion After Intravitreal Injection of Ranibizumab for Diabetic Macular Edema
By:  Dimitrios Stylianos Kontadakis, MD; Ilaria Zucchiatti, MD; Maria Lucia Cascavilla, MD; Maurizio Battaglia Parodi, MD; Stefano Vergallo, MD; Alessandro Papayannis, MD; Francesco Bandello, MD
This report highlights the need to monitor patients for vascular complications of anti-VEGF therapy


By:  Jason S. Slakter, M.D.
From the editor-in-chief

Subspecialty News
By:  Jack Persico, Executive Editor
Dr. Ambati: In the forefront of AMD research; news from the Retinal Congress; and more

Journal Club
New department

Coding Q&A
By:  Riva Lee Asbell
Medicare rulings on intravitreal injections

Focus On
By:  Leslie Goldberg, Associate Editor
Autofluorescence and disease progress

Clinical Trial Spotlight
By:  Andrew E. Mathis, PhD, Medical Editor
iSONEP targets S1P in AMD